Title: Phosphodiesterase‐5 Inhibitors in Pulmonary Arterial Hypertension
Abstract: This chapter contains sections titled: The origins of phosphodiesterase-5 inhibitor development Pulmonary hypertension as a new indication for phosphodiesterase-5 inhibitor treatment Role of phosphodiesterase-5 in the pulmonary vasculature Clinical experience with sildenafil for the treatment of chronic pulmonary hypertension Pivotal trial and approval of sildenafil for the treatment of pulmonary arterial hypertension (SUPER-1 study) Other phosphodiesterase-5 inhibitors Combination therapy Potential new indications for phosphodiesterase-5 inhibitors outside pulmonary arterial hypertension Conclusions References
Publication Year: 2008
Publication Date: 2008-05-21
Language: en
Type: other
Indexed In: ['crossref']
Access and Citation
Cited By Count: 2
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot